| Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial A Palumbo, S Bringhen, T Caravita, E Merla, V Capparella, V Callea, ... The Lancet 367 (9513), 825-831, 2006 | 1037 | 2006 |
| Cardiovascular events and intensity of treatment in polycythemia vera R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ... N Engl J Med 368, 22-33, 2013 | 819 | 2013 |
| Inherited thrombophilia: pathogenesis, clinical syndromes, and management V De Stefano, G Finazzi, PM Mannucci BLOOD-NEW YORK- 87, 3531-3544, 1996 | 733 | 1996 |
| The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation V De Stefano, I Martinelli, PM Mannucci, K Paciaroni, P Chiusolo, ... New England Journal of Medicine 341 (11), 801-806, 1999 | 662 | 1999 |
| Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia AM Vannucchi, E Antonioli, P Guglielmelli, A Rambaldi, G Barosi, ... Blood, The Journal of the American Society of Hematology 110 (3), 840-846, 2007 | 595 | 2007 |
| Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis) T Barbui, G Finazzi, A Carobbio, J Thiele, F Passamonti, E Rumi, ... Blood, The Journal of the American Society of Hematology 120 (26), 5128-5133, 2012 | 575 | 2012 |
| Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families I Martinelli, PM Mannucci, V De Stefano, E Taioli, V Rossi, F Crosti, ... Blood, The Journal of the American Society of Hematology 92 (7), 2353-2358, 1998 | 565 | 1998 |
| Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry G Finazzi, V Brancaccio, M Moia, N Ciavarella, MG Mazzucconi, ... The American journal of medicine 100 (5), 530-536, 1996 | 540 | 1996 |
| Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism J Emmerich, FR Rosendaal, M Cattaneo, M Margaglione, V De Stefano, ... Thrombosis and haemostasis 86 (09), 809-816, 2001 | 507 | 2001 |
| Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera R Landolfi, L Di Gennaro, T Barbui, V De Stefano, G Finazzi, RM Marfisi, ... Blood 109 (6), 2446-2452, 2007 | 487 | 2007 |
| Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments V De Stefano, T Za, E Rossi, AM Vannucchi, M Ruggeri, E Elli, C Micò, ... haematologica 93 (3), 372-380, 2008 | 373 | 2008 |
| Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with … M Cavo, L Pantani, MT Petrucci, F Patriarca, E Zamagni, D Donnarumma, ... Blood, The Journal of the American Society of Hematology 120 (1), 9-19, 2012 | 366* | 2012 |
| Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients V De Stefano, P Chiusolo, K Paciaroni, I Casorelli, E Rossi, M Molinari, ... Blood, The Journal of the American Society of Hematology 91 (10), 3562-3565, 1998 | 349 | 1998 |
| Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia F Zaja, M Baccarani, P Mazza, M Bocchia, L Gugliotta, A Zaccaria, ... Blood, The Journal of the American Society of Hematology 115 (14), 2755-2762, 2010 | 310 | 2010 |
| Screening for inherited thrombophilia: indications and therapeutic implications V De Stefano, E Rossi, K Paciaroni, G Leone haematologica 87 (10), 1095-1108, 2002 | 275 | 2002 |
| Epidemiology of factor V Leiden: clinical implications V de Stefano, P Chiusolo, K Paciaroni, G Leone Seminars in thrombosis and hemostasis 24 (04), 367-379, 1998 | 267 | 1998 |
| Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders V De Stefano, A Fiorini, E Rossi, T Za, G Farina, P Chiusolo, S Sica, ... Journal of Thrombosis and Haemostasis 5 (4), 708-714, 2007 | 253 | 2007 |
| Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium I Martinelli, V De Stefano, E Taioli, K Paciaroni, E Rossi, MM Pier Thrombosis and haemostasis 87 (05), 791-795, 2002 | 253 | 2002 |
| A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis F Passamonti, T Giorgino, B Mora, P Guglielmelli, E Rumi, M Maffioli, ... Leukemia 31 (12), 2726-2731, 2017 | 250 | 2017 |
| The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment V De Stefano, F Sora, E Rossi, P Chiusolo, L Laurenti, L Fianchi, G Zini, ... Journal of Thrombosis and Haemostasis 3 (9), 1985-1992, 2005 | 245 | 2005 |
